Skip Navigation

European Heart Journal 2002 23(2):173-175; doi:10.1053/euhj.2001.2984
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Scheller, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Scheller, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letters to the Editors

A reply

B. Scheller

University of Saarland, Internal Medicine III, Homburg/Saar, Germany

References

  1. Scheller B, Hennen B, Hennen B, Pohl A, Schieffer H, Markwirth T. Acute and subacute stent occlusion; risk-reduction by ionic contrast media. Eur Heart J. 2001;22:385–391[Abstract/Free Full Text]
  2. Scheller B. A reply. Letter to the editor. Eur Heart J. 2001;22:2029–2031[Free Full Text]
  3. Bertrand ME, Esplugas E, Piessens J, Rasch W. Influence of a non-ionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty VIP Trial Investigators. Circulation. 2000;101:131–136[Abstract/Free Full Text]
  4. Davidson CJ, Laskey WK, Hermiller JB. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation. 2000;101:217–227[Free Full Text]
  5. Idee JM, Corot C. Thrombotic risk associated with the use of iodinated contrast media in interventional cardiology: pathophysiology and clinical aspects. Fundam Clin Pharmacol. 1999;13:613–623[ISI][Medline]
  6. Chronos NA, Goodall AH, Wilson DJ, Sigwart U, Buller NP. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation. 1993;88:2035–2044[Abstract/Free Full Text]
  7. Hay K, Bull S. An analysis of platelet activation and aggregation produced by three classes of contrast media. JVIR. 1995;6:211–217[ISI][Medline]
  8. Fay WP, Parker AC. Effects of radiographic contrast agents on thrombin formation and activity. Thromb Haemost. 1998;80:266–272[ISI][Medline]
  9. Li X, Gabriel DA. Differences between contrast media in the inhibition of platelet activation by specific platelet agonists. Acad Radiol. 1997;4:108–114[CrossRef][ISI][Medline]
  10. Melton LG, Dehmer GJ, Gabriel DA. Alterations in fibrin detected in coronary sinus blood after heparin and coronary angiography with a non-ionic contrast agent (iohexol). Am J Cardiol. 1998;82:295–298[CrossRef][ISI][Medline]
  11. Casalani E. Role of low-osmolality contrast media in thromboembolic complications: scanning electron microscopy study. Radiology. 1992;183:741–744[Abstract/Free Full Text]
  12. Qureshi N, denHeijer P, Crijns HJ. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and non-ionic low osmolality contrast media in unstable angina. Am J Cardiol. 1997;80:700–704[CrossRef][ISI][Medline]
  13. Esplugas E, Cequier A, Jara F. Risk of thrombosis during coronary angioplasty with low osmolality contrast media. Am J Cardiol. 1991;68:102–104
  14. Gasperetti CM, Feldman MD, Burwell LR. Influence of contrast media on thrombus formation during coronary angioplasty. J Am Coll Cardiol. 18;:443–450
  15. Piessens JH, Stammen F, Vrolix MC. Effects of an ionic versus a non-ionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty. Cathet Cardiovasc Diagn. 1993;28:99–105[ISI][Medline]
  16. Lefèvre T, Adjeroud N, Royer T, Glatt B, Morice MC. Influence of contrast media on the results of percutaneous transluminal coronary angioplasty with provisional stenting: a comparative study. J Invas Cardiol. 1998;10:380–384[ISI][Medline]
  17. Fleisch M, Mühlhauser B, Garachemani A. Impact of ionic (ioxaglate) and non-ionic (ioversol) contrast media on PTCA related complications. J Am Coll Cardiol. 1999;33:85A
  18. Schräder R, Esch I, Ensslen R. A randomized trial comparing the impact of a non-ionic (Iomerprol) versus an ionic (ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. J Am Coll Cardiol. 1999;33:395–402[Abstract/Free Full Text]
  19. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation. 1989;80:198–205[Abstract/Free Full Text]
  20. Grines CL, Schreiber TL, Savas V. A randomized trial of low osmolar ionic versus non-ionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1996;27:1381–1386[Abstract]
  21. Batchelor WB, Granger CB, Kleiman N. A comparison of ionic versus non-ionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Am J Cardiol. 2000;85:692–697[CrossRef][ISI][Medline]
  22. Aguirre FV, Topol EJ, Donohue TJ. Impact of ionic and non-ionic contrast media on post-PTCA ischemic complications: results from the EPIC trial. J Am Coll Cardiol. 1995;25:8A
  23. Gawaz M, Neumann FJ, Schomig A. Evaluation of platelet membrane glycoproteins in coronary artery disease: consequences for diagnosis and therapy. Circulation. 1999;99:E1–E11
  24. Markou CP, Chronos NA, Hanson SR. Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates. Thromb Haemost. 2001;85:488–493[ISI][Medline]
  25. Heptinstall S, White A, Edwards N. Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice? Br J Haematol. 1998;103:1023–1030[CrossRef][ISI][Medline]
  26. D'Anglemont de Tassigny A, Idee JM, Corot C. Comparative effects of ionic and nonionic iodinated low osmolar contrast media on platelet function with the PFA100 (platelet function analyzer). Invest Radiol. 2001;36:276–282[CrossRef][ISI][Medline]
  27. Gasperetti CM, Gonias SL, Gimple LW, Powers ER. Platelet activation during coronary angioplasty in humans. Circulation. 1993;88:2728–2734[Abstract/Free Full Text]
  28. Batchelor W. From COURT to HOMBURG. Letter to the editor. Eur Heart J. 2001;22:2026–2080[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Scheller, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Scheller, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?